Want to see GB:OPT full AI Analyst Report?
Optima Health PLC (OPT) Ratios
Optima Health PLC Ratios
GB:OPT's free cash flow for Q4 2024 was $2.17M. For the 2024 fiscal year, GB:OPT's free cash flow was decreased by $-1.10M and operating cash flow was $3.27M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.68 | 0.84 | 0.82 | 0.42 | 0.43 |
| Quick Ratio | 2.68 | 0.84 | 0.81 | 0.42 | 0.43 |
| Cash Ratio | 1.17 | 0.32 | 0.26 | 0.16 | 0.14 |
| Solvency Ratio | 0.24 | 0.07 | 0.20 | 0.12 | 0.03 |
| Operating Cash Flow Ratio | 0.21 | 0.21 | 0.41 | 0.08 | -0.02 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 10.55 | 1.28 | 0.12 | -0.03 |
| Net Current Asset Value | $ -15.97M | $ -129.53M | $ -22.31M | $ -64.37M | $ -45.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.27 | 0.06 | 0.26 | 0.18 |
| Debt-to-Equity Ratio | 0.13 | 0.56 | 0.00 | 0.45 | 0.27 |
| Debt-to-Capital Ratio | 0.11 | 0.36 | 1.00 | 0.31 | 0.21 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.34 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.30 | 2.10 | 0.00 | 1.76 | 1.52 |
| Debt Service Coverage Ratio | 19.14 | 4.84 | 0.96 | 0.22 | 0.06 |
| Interest Coverage Ratio | 10.79 | 2.54 | -5.34 | 6.31 | -29.12 |
| Debt to Market Cap | 0.19 | 0.54 | 0.07 | 0.40 | 0.24 |
| Interest Debt Per Share | 0.43 | 1.08 | 0.14 | 0.65 | 0.38 |
| Net Debt to EBITDA | 0.50 | 4.83 | 0.42 | 4.08 | 15.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.45% | 22.02% | 32.89% | 32.02% | 35.92% |
| EBIT Margin | 6.83% | 3.29% | -0.65% | 0.74% | -2.21% |
| EBITDA Margin | 13.00% | 12.58% | 9.07% | 9.59% | 7.78% |
| Operating Profit Margin | 6.83% | 3.29% | -0.65% | 0.73% | -2.21% |
| Pretax Profit Margin | 2.45% | 2.05% | -0.77% | 0.62% | -2.28% |
| Net Profit Margin | 1.57% | 1.16% | -0.98% | 1.38% | -1.10% |
| Continuous Operations Profit Margin | 1.57% | 1.16% | -0.98% | 1.38% | -1.10% |
| Net Income Per EBT | 64.16% | 56.80% | 126.52% | 222.97% | 48.14% |
| EBT Per EBIT | 35.89% | 62.25% | 118.72% | 84.50% | 103.23% |
| Return on Assets (ROA) | 0.76% | 0.39% | -0.51% | 0.71% | -0.13% |
| Return on Equity (ROE) | 0.98% | 0.83% | 0.00% | 1.24% | -0.19% |
| Return on Capital Employed (ROCE) | 3.49% | 1.37% | -0.40% | 0.57% | -0.34% |
| Return on Invested Capital (ROIC) | 2.23% | 0.78% | -0.38% | 0.42% | -0.14% |
| Return on Tangible Assets | 3.98% | 2.00% | -3.54% | 3.99% | -0.97% |
| Earnings Yield | 1.88% | 0.87% | -0.81% | 1.19% | -0.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.87 | 3.48 | 6.68 | 6.19 | 1.75 |
| Payables Turnover | 46.79 | 2.63 | 24.73 | 20.13 | 6.19 |
| Inventory Turnover | 720.08 | 236.97 | 1181.16 | 481.06 | 305.21 |
| Fixed Asset Turnover | 14.34 | 8.97 | 23.72 | 16.49 | 4.83 |
| Asset Turnover | 0.48 | 0.34 | 0.53 | 0.51 | 0.12 |
| Working Capital Turnover Ratio | 13.52 | 22.08 | -4.35 | -3.16 | 0.00 |
| Cash Conversion Cycle | 54.85 | -32.34 | 40.23 | 41.63 | 150.88 |
| Days of Sales Outstanding | 62.14 | 105.01 | 54.68 | 59.00 | 208.69 |
| Days of Inventory Outstanding | 0.51 | 1.54 | 0.31 | 0.76 | 1.20 |
| Days of Payables Outstanding | 7.80 | 138.89 | 14.76 | 18.14 | 59.01 |
| Operating Cycle | 62.65 | 106.55 | 54.99 | 59.76 | 209.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | 0.16 | 0.14 | 0.07 | -0.01 |
| Free Cash Flow Per Share | -0.02 | 0.15 | 0.11 | 0.03 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.11 | 13.10 | 4.51 | 1.57 | -1.05 |
| Capital Expenditure Coverage Ratio | 0.72 | 13.10 | 4.51 | 1.57 | -1.05 |
| Operating Cash Flow Coverage Ratio | 0.12 | 0.15 | 1.03 | 0.11 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.12 | 0.12 | 0.06 | -0.04 |
| Free Cash Flow Yield | -1.21% | 8.21% | 7.46% | 1.79% | -1.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 53.11 | 114.79 | -123.78 | 84.20 | -544.93 |
| Price-to-Sales (P/S) Ratio | 0.84 | 1.33 | 1.21 | 1.16 | 5.99 |
| Price-to-Book (P/B) Ratio | 0.52 | 0.95 | 0.00 | 1.05 | 1.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -82.58 | 12.18 | 13.41 | 55.92 | -82.14 |
| Price-to-Operating Cash Flow Ratio | 32.70 | 11.25 | 10.44 | 20.33 | -160.35 |
| Price-to-Earnings Growth (PEG) Ratio | -0.15 | -2.23 | 0.74 | -0.11 | 0.00 |
| Enterprise Value Multiple | 6.94 | 15.42 | 13.75 | 16.20 | 92.59 |
| Enterprise Value | 94.75M | 233.98M | 138.28M | 179.19M | 161.21M |
| EV to EBITDA | 6.94 | 15.42 | 13.75 | 16.20 | 92.59 |
| EV to Sales | 0.90 | 1.94 | 1.25 | 1.55 | 7.20 |
| EV to Free Cash Flow | -89.05 | 17.74 | 13.83 | 74.76 | -98.78 |
| EV to Operating Cash Flow | 35.26 | 16.39 | 10.77 | 27.18 | -192.83 |
| Tangible Book Value Per Share | -0.17 | -1.29 | -0.20 | -0.65 | -0.46 |
| Shareholders’ Equity Per Share | 3.27 | 1.89 | 0.00 | 1.44 | 1.42 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.36 | 0.43 | -0.27 | -1.23 | 0.52 |
| Revenue Per Share | 2.04 | 1.35 | 1.25 | 1.30 | 0.25 |
| Net Income Per Share | 0.03 | 0.02 | -0.01 | 0.02 | -0.00 |
| Tax Burden | 0.64 | 0.57 | 1.27 | 2.23 | 0.48 |
| Interest Burden | 0.36 | 0.62 | 1.19 | 0.84 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.19 | 0.17 | 0.14 | 0.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.04 | 10.17 | -15.01 | 9.23 | 1.64 |
Currency in GBP
